Classification of colorectal cancer based on correlation of clinical, morphological and molecular features
The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Abstract
Over the last 20 years it has become clear that colorectal cancer (CRC) evolves through multiple pathways. These pathways may be defined on the basis of two molecular features: (i) DNA microsatellite instability (MSI) status stratified as MSI‐high (MSI‐H), MSI‐low (MSI‐L) and MS stable (MSS), and (ii) CpG island methylator phenotype (CIMP) stratified as CIMP‐high, CIMP‐low and CIMP‐negative (CIMP‐neg). In this review the morphological correlates of five molecular subtypes are outlined: Type 1 (CIMP‐high/MSI‐H/BRAF mutation), Type 2 (CIMP‐high/MSI‐L or MSS/BRAF mutation), Type 3 (CIMP‐low/MSS or MSI‐L/KRAS mutation), Type 4 (CIMP‐neg/MSS) and Type 5 or Lynch syndrome (CIMP‐neg/MSI‐H). The molecular pathways are determined at an early evolutionary stage and are fully established within precancerous lesions. Serrated polyps are the precursors of Types 1 and 2 CRC, whereas Types 4 and 5 evolve through the adenoma–carcinoma sequence. Type 3 CRC may arise within either type of polyp. Types 1 and 4 are conceived as having few, if any, molecular overlaps with each other, whereas Types 2, 3 and 5 combine the molecular features of Types 1 and 4 in different ways. This approach to the classification of CRC should accelerate understanding of causation and will impact on clinical management in the areas of both prevention and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
World Health Organization Classification of Tumours
Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Clues to the Pathogenesis of Familial Colorectal Cancer
Aaltonen, L. A., Peltomäki, P., Leach, F. S., Sistonen, P., Pylkkänen, L., Mecklin, J.-P., Järvinen, H., Powell, S. M., Jen, J., Hamilton, S. R., et al. (1993) · Science · doi:10.1126/science.8484121 · Cited by 2,710
Ionov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D., & Perucho, M. (1993) · Nature · doi:10.1038/363558a0 · Cited by 2,708
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,270
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160 · cited 4×
“It might be supposed that this group is homogeneous at the molecular level and comprises CRC with mutation of APC, KRAS and TP53.”
BackgroundInfluentialWeisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
Self-citation
Cited by
Brenner, H., Kloor, M., & Pox, C. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61649-9 · Cited by 2,762
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
Keum, N., & Giovannucci, E. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0189-8 · Cited by 2,661
Global colorectal cancer burden in 2020 and projections to 2040
Xi, Y., & Xu, P. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101174 · Cited by 2,434
Molecular Basis of Colorectal Cancer
Markowitz, S. D., & Bertagnolli, M. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804588 · Cited by 2,052
Landon, M., Saam, J., Brown, K. L., Moyes, K., Evans, B., & Wenstrup, R. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,939
Molecular Genetics of Colorectal Cancer
Fearon, E. R. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130235 · Cited by 1,805
Marisa, L., de Reyniès, A., Duval, A., Selves, J., Gaub, M. P., Vescovo, L., Etienne-Grimaldi, M.-C., Schiappa, R., Guenot, D., Ayadi, M., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001453 · Cited by 1,507
Lynch, H., Lynch, P., Lanspa, S., Snyder, C., Lynch, J., & Boland, C. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01230.x · Cited by 840
Ogino, S., Nosho, K., Kirkner, G. J., Kawasaki, T., Meyerhardt, J. A., Loda, M., Giovannucci, E. L., & Fuchs, C. S. (2009) · Gut · doi:10.1136/gut.2008.155473 · Cited by 777
Venderbosch, S., Nagtegaal, I. D., Maughan, T. S., Smith, C. G., Cheadle, J. P., Fisher, D., Kaplan, R., Quirke, P., Seymour, M. T., Richman, S. D., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0332 · Cited by 772
Epigenetics and colorectal cancer
Lao, V. V., & Grady, W. M. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.173 · Cited by 736
Colorectal carcinoma: Pathologic aspects.
Fleming, M., Ravula, S., Tatishchev, S. F., & Wang, H. L. (2012) · PubMed · doi:10.3978/j.issn.2078-6891.2012.030 · Cited by 713
Hutchins, G., Southward, K., Handley, K., Magill, L., Beaumont, C., Stahlschmidt, J., Richman, S., Chambers, P., Seymour, M., Kerr, D., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1366 · Cited by 681
Voulgari, A., & Pintzas, A. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.03.002 · Cited by 671
Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features
Missiaglia, E., Jacobs, B., D'Ario, G., Di Narzo, A. F., Soneson, C., Budinska, E., Popovici, V., Vecchione, L., Gerster, S., Yan, P., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu275 · Cited by 646
Update on the serrated pathway to colorectal carcinoma
Snover, D. C. (2011) · Human Pathology · doi:10.1016/j.humpath.2010.06.002 · Cited by 641
Genome-scale analysis of aberrant DNA methylation in colorectal cancer
Hinoue, T., Weisenberger, D. J., Lange, C. P. E., Shen, H., Byun, H.-M., Van Den Berg, D., Malik, S., Pan, F., Noushmehr, H., van Dijk, C. M., et al. (2012) · Genome Research · doi:10.1101/gr.117523.110 · Cited by 601
Nonpolypoid neoplastic lesions of the colorectal mucosa
Kudo, S. E., Lambert, R., Allen, J. I., Fujii, H., Fujii, T., Kashida, H., Matsuda, T., Mori, M., Saito, H., Shimoda, T., et al. (2008) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2008.07.052 · Cited by 530
Self-citationOgino, S., Chan, A. T., Fuchs, C. S., & Giovannucci, E. (2011) · Gut · doi:10.1136/gut.2010.217182 · Cited by 522
Deficient mismatch repair system in patients with sporadic advanced colorectal cancer
Koopman, M., Kortman, G. A. M., Mekenkamp, L., Ligtenberg, M. J. L., Hoogerbrugge, N., Antonini, N. F., Punt, C. J. A., & van Krieken, J. H. J. M. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604867 · Cited by 515
The serrated pathway to colorectal carcinoma: current concepts and challenges
Bettington, M., Walker, N., Clouston, A., Brown, I., Leggett, B., & Whitehall, V. (2013) · Histopathology · doi:10.1111/his.12055 · Cited by 502
Transcriptome Profile of Human Colorectal Adenomas
Sabates-Bellver, J., Van der Flier, L. G., de Palo, M., Cattaneo, E., Maake, C., Rehrauer, H., Laczko, E., Kurowski, M. A., Bujnicki, J. M., Menigatti, M., et al. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0267 · Cited by 496
Lactate and lactylation in cancer
Chen, J., Huang, Z., Chen, Y., Tian, H., Chai, P., Shen, Y., Yao, Y., Xu, S., Ge, S., & Jia, R. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02082-x · Cited by 477
Molecular Classification and Correlates in Colorectal Cancer
Ogino, S., & Goel, A. (2008) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.070082 · Cited by 460
Imai, K., & Yamamoto, H. (2008) · Carcinogenesis · doi:10.1093/carcin/bgm228 · Cited by 429
Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer
Cheng, X., Xu, X., Chen, D., Zhao, F., & Wang, W. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.082 · Cited by 417
Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer
Budinska, E., Popovici, V., Tejpar, S., D'Ario, G., Lapique, N., Sikora, K. O., Di Narzo, A. F., Yan, P., Hodgson, J. G., Weinrich, S., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4212 · Cited by 409
Association Between Molecular Subtypes of Colorectal Cancer and Patient Survival
Phipps, A. I., Limburg, P. J., Baron, J. A., Burnett-Hartman, A. N., Weisenberger, D. J., Laird, P. W., Sinicrope, F. A., Rosty, C., Buchanan, D. D., Potter, J. D., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.09.038 · Cited by 401
BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer
Yokota, T., Ura, T., Shibata, N., Takahari, D., Shitara, K., Nomura, M., Kondo, C., Mizota, A., Utsunomiya, S., Muro, K., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.19 · Cited by 401
CIMP Status of Interval Colon Cancers: Another Piece to the Puzzle
Arain, M. A., Sawhney, M., Sheikh, S., Anway, R., Thyagarajan, B., Bond, J. H., & Shaukat, A. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.699 · Cited by 382
The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes
Kim, T.-M., Laird, P. W., & Park, P. J. (2013) · Cell · doi:10.1016/j.cell.2013.10.015 · Cited by 380
Testa, U., Pelosi, E., & Castelli, G. (2018) · Medical Sciences · doi:10.3390/medsci6020031 · Cited by 374
Chang, D. T., Pai, R. K., Rybicki, L. A., Dimaio, M. A., Limaye, M., Jayachandran, P., Koong, A. C., Kunz, P. A., Fisher, G. A., Ford, J. M., et al. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.61 · Cited by 352
Sessile Serrated Adenoma (SSA) vs. Traditional Serrated Adenoma (TSA)
Torlakovic, E. E., Gomez, J. D., Driman, D. K., Parfitt, J. R., Wang, C., Benerjee, T., & Snover, D. C. (2008) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318157f002 · Cited by 348
Defining ‘chromosomal instability’
Geigl, J. B., Obenauf, A. C., Schwarzbraun, T., & Speicher, M. R. (2008) · Trends in Genetics · doi:10.1016/j.tig.2007.11.006 · Cited by 341
Variation in the Detection of Serrated Polyps in an Average Risk Colorectal Cancer Screening Cohort
Hetzel, J. T., Huang, C. S., Coukos, J. A., Omstead, K., Cerda, S. R., Yang, S., O'Brien, M. J., & Farraye, F. A. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.315 · Cited by 335
Molecular Markers Identify Subtypes of Stage III Colon Cancer Associated With Patient Outcomes
Sinicrope, F. A., Shi, Q., Smyrk, T. C., Thibodeau, S. N., Dienstmann, R., Guinney, J., Bot, B. M., Tejpar, S., Delorenzi, M., Goldberg, R. M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.09.041 · Cited by 330
Ogino, S., Nosho, K., Kirkner, G. J., Shima, K., Irahara, N., Kure, S., Chan, A. T., Engelman, J. A., Kraft, P., Cantley, L. C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.6544 · Cited by 323
Strum, W. B. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1513581 · Cited by 312
Nosho, K., Irahara, N., Shima, K., Kure, S., Kirkner, G. J., Schernhammer, E. S., Hazra, A., Hunter, D. J., Quackenbush, J., Spiegelman, D., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003698 · Cited by 311
DNA methylation markers in colorectal cancer
Kim, M. S., Lee, J., & Sidransky, D. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9207-6 · Cited by 303
Molecular pathways in colorectal cancer
Al‐Sohaily, S., Biankin, A., Leong, R., Kohonen‐Corish, M., & Warusavitarne, J. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07200.x · Cited by 298
Serrated Polyps and Colorectal Cancer: New Pathway to Malignancy
Noffsinger, A. E. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092317 · Cited by 282
S3-Leitlinie „Kolorektales Karzinom” – Aktualisierung 2008
Schmiegel, W., Reinacher-Schick, A., Arnold, D., Graeven, U., Heinemann, V, Porschen, R., Riemann, J., Rödel, C., Sauer, R., Wieser, M., et al. (2008) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2008-1027726 · Cited by 274
Ogino, S., Kawasaki, T., Nosho, K., Ohnishi, M., Suemoto, Y., Kirkner, G. J., & Fuchs, C. S. (2008) · International Journal of Cancer · doi:10.1002/ijc.23470 · Cited by 261
DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome
Poulogiannis, G., Frayling, I. M., & Arends, M. J. (2010) · Histopathology · doi:10.1111/j.1365-2559.2009.03392.x · Cited by 241
“Journal compilation 2010 Blackwell Publishing Ltd, Histopathology, 56, 167–179. evidence that a tumour phenotype manifesting MSI-L may be associated with sporadic colorectal tumorigenesis and a cancer predisposition condition distinct from LS.24,25 The components of the MMR system are highly conserved in both pro- and…”
BackgroundInfluentialDistinct gut microbiome patterns associate with consensus molecular subtypes of colorectal cancer
Purcell, R. V., Visnovska, M., Biggs, P. J., Schmeier, S., & Frizelle, F. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-11237-6 · Cited by 227
“Studies of molecular features, such as BRAF, KRAS and TP53 mutation status, microsatellite instability (MSI), CpG island methylator phenotype (CIMP), somatic copy number alterations (SCNA), and activation of various molecular pathways such as WNT and MYC, have been used with some success to stratify CRC into subgroups…”
BackgroundDeepCC: a novel deep learning-based framework for cancer molecular subtype classification
Gao, F., Wang, W., Tan, M., Zhu, L., Zhang, Y., Fessler, E., Vermeulen, L., & Wang, X. (2019) · Oncogenesis · doi:10.1038/s41389-019-0157-8 · Cited by 226
Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: The role of inflammation
Lee, C. S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i14.3751 · Cited by 224
Wei, Z., Cao, S., Liu, S., Yao, Z., Sun, T., Li, Y., Li, J., Zhang, D., & Zhou, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.10064 · Cited by 222
Rad, R., Cadiñanos, J., Rad, L., Varela, I., Strong, A., Kriegl, L., Constantino-Casas, F., Eser, S., Hieber, M., Seidler, B., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.05.014 · Cited by 216
“Because APC mutations are less frequent in the BRAF mutant CRC subset, it was largely assumed that BRAF-associated intestinal tumorigenesis is Wnt-independent (Samowitz et al., 2007; Jass, 2007).”
BackgroundInfluentialRelevance, Pathogenesis, and Testing Algorithm for Mismatch Repair–Defective Colorectal Carcinomas
Funkhouser, W. K., Lubin, I. M., Monzon, F. A., Zehnbauer, B. A., Evans, J. P., Ogino, S., & Nowak, J. A. (2012) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2011.11.001 · Cited by 189
“Lynch and sporadic subgroups of dMMR CRC can show unique morphologic characteristics compared with pMMR CRC.(17) Many MSI-H CRCs show statistically significant increases in tumor-infiltrating lymphocytes, Crohn’s-like reaction, and mucin production and a significant decrease in intraglandular neutrophil-rich (“dirty”)…”
BackgroundInfluentialDarband, S. G., Kaviani, M., Yousefi, B., Sadighparvar, S., Pakdel, F. G., Attari, J. A., Mohebbi, I., Naderi, S., & Majidinia, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26595 · Cited by 189
“susceptible to frame-shift mutations and base-pair substitutions, which caused by the loss of DNAmismatch repair (MMR) activity (Jass, 2007).”
BackgroundBennecke, M., Kriegl, L., Bajbouj, M., Retzlaff, K., Robine, S., Jung, A., Arkan, M. C., Kirchner, T., & Greten, F. R. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.06.013 · Cited by 186
“Murine Serrated Cancers Are CIMP Negative and MSI-L/MSS Human serrated tumors harboring KRAS mutations frequently exhibit a CIMP-low/CIMP-negative and microsatellite stable or low profile (MSS/MSI-L) in contrast to tumors with BRAF mutations that are characterized by extensive methylation of certain CpG islands (CIMP-…”
BackgroundInfluentialS3-Leitlinie Kolorektales Karzinom Version 1.0 - Juni 2013 AWMF-Registernummer: 021/007OL
Pox, C., Aretz, S., Bischoff, S., Graeven, U., Hass, M., Heußner, P., Hohenberger, W., Holstege, A., Hübner, J., Kolligs, F., et al. (2013) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0033-1350264 · Cited by 179
Colonoscopy screening and surveillance guidelines
Saito, Y., Oka, S., Kawamura, T., Shimoda, R., Sekiguchi, M., Tamai, N., Hotta, K., Matsuda, T., Misawa, M., Tanaka, S., et al. (2021) · Digestive Endoscopy · doi:10.1111/den.13972 · Cited by 170
The Clinical Significance of Serrated Polyps
Huang, C. S., Farraye, F. A., Yang, S., & O'Brien, M. J. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.429 · Cited by 167
Rosty, C., Young, J. P., Walsh, M. D., Clendenning, M., Walters, R. J., Pearson, S., Pavluk, E., Nagler, B., Pakenas, D., Jass, J. R., et al. (2013) · Modern Pathology · doi:10.1038/modpathol.2012.240 · Cited by 162
Self-citationTGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype
Fessler, E., Drost, J., van Hooff, S. R., Linnekamp, J. F., Wang, X., Jansen, M., De Sousa E Melo, F., Prasetyanti, P. R., IJspeert, J. E., Franitza, M., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606184 · Cited by 159
“SSAs following the serrated neoplasia pathway have been suggested to harbor the potential to progress either to good- or to poor-prognosis CRCs based on molecular markers (Jass, 2007; Phipps et al, 2015).”
InfluentialCarragher, L. A. S., Snell, K. R., Giblett, S. M., Aldridge, V. S. S., Patel, B., Cook, S. J., Winton, D. J., Marais, R., & Pritchard, C. A. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000099 · Cited by 144
“It is now known that these molecular features are concordant with cancers that have a serrated histopathology, thus consolidating the classification of a distinct serrated neoplasia pathway originally pioneered by Jeremy Jass (Jass, 2007a).”
InfluentialComprehensive Assessment of Diet Quality and Risk of Precursors of Early-Onset Colorectal Cancer
Zheng, X., Hur, J., Nguyen, L. H., Liu, J., Song, M., Wu, K., Smith-Warner, S. A., Ogino, S., Willett, W. C., Chan, A. T., et al. (2021) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djaa164 · Cited by 136
Interval colorectal cancer after colonoscopy: exploring explanations and solutions
Adler, J., & Robertson, D. J. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.365 · Cited by 129
Houwen, B. B. S. L., Hassan, C., Coupé, V. M. H., Greuter, M. J. E., Hazewinkel, Y., Vleugels, J. L. A., Antonelli, G., Bustamante-Balén, M., Coron, E., Cortas, G. A., et al. (2022) · Endoscopy · doi:10.1055/a-1689-5130 · Cited by 99
“As the malignant potential of SSLs is increasingly being emphasized, in this simulation approach, the impact of correctly optically diagnosing diminutive SSLs was also assessed [21, 22].”
BackgroundDunne, P. D., Alderdice, M., O'Reilly, P. G., Roddy, A. C., McCorry, A. M. B., Richman, S., Maughan, T., McDade, S. S., Johnston, P. G., Longley, D. B., et al. (2017) · Nature Communications · doi:10.1038/ncomms15657 · Cited by 94
Consensus molecular subtype classification of colorectal adenomas
Komor, M. A., Bosch, L. J., Bounova, G., Bolijn, A. S., Delis‐van Diemen, P. M., Rausch, C., Hoogstrate, Y., Stubbs, A. P., de Jong, M., Jenster, G., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5129 · Cited by 86
“More recently, a serrated pathway has been introduced, with sessile serrated lesions being precursors of CRC [50].”
BackgroundWilliams, D. S., Mouradov, D., Jorissen, R. N., Newman, M. R., Amini, E., Nickless, D. K., Teague, J. A., Fang, C. G., Palmieri, M., Parsons, M. J., et al. (2019) · Gut · doi:10.1136/gutjnl-2017-315664 · Cited by 79
Farkas, S. A., Vymetalkova, V., Vodickova, L., Vodicka, P., & Nilsson, T. K. (2014) · Epigenomics · doi:10.2217/epi.14.7 · Cited by 67
Methylation-Based Therapies for Colorectal Cancer
Cervena, K., Siskova, A., Buchler, T., Vodicka, P., & Vymetalkova, V. (2020) · Cells · doi:10.3390/cells9061540 · Cited by 57
Sessile serrated polyps and colon cancer prevention
Rashtak, S., Rego, R., Sweetser, S. R., & Sinicrope, F. A. (2017) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0264 · Cited by 47
Chang, S.-C., Lin, P.-C., Lin, J.-K., Lin, C.-H., Yang, S.-H., Liang, W.-Y., Chen, W.-S., & Jiang, J.-K. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4899-z · Cited by 31
DNA Repair Capacity and Response to Treatment of Colon Cancer
Vodicka, P., Vodenkova, S., Buchler, T., & Vodickova, L. (2019) · Pharmacogenomics · doi:10.2217/pgs-2019-0070 · Cited by 19
Loughrey, M. B. (2020) · Histopathology Reporting · doi:10.1007/978-3-030-27828-1_6 · Cited by 6
Metadata
- Authors
- Jass, J. R.
- Venue
- Histopathology
- Publisher
- Wiley
- Published
- 2006-12-14
- Volume
- 50
- Issue
- 1
- Pages
- 113-130
- ISSN
- 0309-0167 (ISSN-L)
- 1365-2559
- OpenAlex
- W2103547637
- Cited by
- 1,384
- References
- 139
- FWCI
- 30.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.